Author: Cillóniz, Catia; Garcia-Vidal, Carolina; Ceccato, Adrian; Torres, Antoni
Title: Antimicrobial Resistance Among Streptococcus pneumoniae Cord-id: tetqfycq Document date: 2018_3_7
ID: tetqfycq
Snippet: Antibiotic resistance in Streptococcus pneumoniae (pneumococcus), the main pathogen responsible for community-acquired pneumonia (CAP), meningitis, bacteremia, and otitis media, is a major concern for clinicians. This pathogen is associated with high rates of morbidity and mortality, especially among children under 2 years old, immunocompromised persons, and the elderly population. The major anti-pneumococcus agents are β-lactams and macrolides, with fluoroquinolones ranking third. The emergenc
Document: Antibiotic resistance in Streptococcus pneumoniae (pneumococcus), the main pathogen responsible for community-acquired pneumonia (CAP), meningitis, bacteremia, and otitis media, is a major concern for clinicians. This pathogen is associated with high rates of morbidity and mortality, especially among children under 2 years old, immunocompromised persons, and the elderly population. The major anti-pneumococcus agents are β-lactams and macrolides, with fluoroquinolones ranking third. The emergence of antibiotic-resistant pneumococcus due to overuse of antibiotics is a global concern. While the discovery of novel classes of antibiotics for the pneumococcus is at a standstill, significant progress in reducing the problem of resistance is associated with antibacterial vaccines. Nevertheless, the World Health Organization recently considered drug-resistant S. pneumoniae as ranking among the 12 bacteria, for which there is an urgent need for new treatments. A challenge is to slow the evolution of new strains that are resistant to the vaccines.
Search related documents:
Co phrase search for related documents- acip immunization practices and long term care facility: 1
- activity broad spectrum and acute ards respiratory distress syndrome: 1, 2, 3
- activity broad spectrum and low concentration: 1, 2, 3
- acute ards respiratory distress syndrome and additional factor: 1, 2
- acute ards respiratory distress syndrome and adequate response: 1, 2
- acute ards respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute ards respiratory distress syndrome and long period: 1, 2
- acute ards respiratory distress syndrome and low concentration: 1
- acute ards respiratory distress syndrome development and liver disease: 1
- acute ards respiratory distress syndrome development and long period: 1
- acute upper respiratory infection and additional factor: 1
- acute upper respiratory infection and low concentration: 1
- additional factor and liver disease: 1, 2, 3, 4, 5, 6
- adequate response and long period: 1
- adequate response and low concentration: 1, 2
- liver disease and long period: 1, 2
- liver disease and long term care facility: 1
- liver disease and low concentration: 1
- long period and low concentration: 1, 2
Co phrase search for related documents, hyperlinks ordered by date